General Medicine and Primary Care
This CME series provides primary care professionals with the knowledge and skill sets needed to effectively provide standard-of-care medicine within the constraints of a busy office setting. Faculty therapeutic area experts address how to overcome barriers preventing optimal patient outcomes by improving guideline adherence, and optimizing practice performance in areas where guidelines are needed.
1-15 of 123
Oral GLP-1 RA Therapy in Type 2 Diabetes and High Cardiovascular Risk
CME/CEOral GLP-1 RA Therapy in Type 2 Diabetes and High Cardiovascular Risk
Brian P. McDonough, MD, FAAFP
Silvio Inzucchi, MD
Jay H. Shubrook, DO, FACOFP, FAAFP
Patient Portal: Leveraging Technology to Improve Safety with Clinical Decision-Making for People with Diabetes
CME/CEPatient Portal: Leveraging Technology to Improve Safety with Clinical Decision-Making for People with Diabetes
Ketan Dhatariya, MBBS, MSc, MD, MS, FRCP, PhD
Eden Miller, DO, D-ACD, D-ABOM
A New Lens on DKA: Leveraging the Latest Tech for Improved Patient Outcomes
CME/CEA New Lens on DKA: Leveraging the Latest Tech for Improved Patient Outcomes
Jennifer Goldman, PharmD, CDCES, BC-ADM-FCCP
Ketan Dhatariya, MBBS, MSc, MD, MS, FRCP, PhD
Mineralocorticoid Receptor Antagonists in Heart Failure: The Evolving Treatment Landscape
CME/CEMineralocorticoid Receptor Antagonists in Heart Failure: The Evolving Treatment Landscape
Javed Butler, MD
Stephen J. Greene, MD
Muthiah Vaduganathan, MD, MPH
Orly Vardeny, MD
From Prevalence to Practice: Practical Screening and Workup for Hypercortisolism in Resistant Hypertension
CME/CEFrom Prevalence to Practice: Practical Screening and Workup for Hypercortisolism in Resistant Hypertension
Jorge Plutzky, MD
Bradley Eilerman, MD, MHI
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
CME/CEReimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
Alireza Atri, MD, PhD
Raymond Scott Turner, MD, PhD
Dani Cabral, MD
- advertisement
The Cortisol Clue: Diagnosing Hypercortisolism in People with Difficult-to-Control Cardiometabolic Conditions
CME/CEThe Cortisol Clue: Diagnosing Hypercortisolism in People with Difficult-to-Control Cardiometabolic Conditions
Hanford Yau, MD, CCD, FACP, FACE
Eden Miller, DO, D-ACD, D-ABOM
Survey Says: Aligning Early Advanced IBD Therapy with Patient Priorities
CME/CESurvey Says: Aligning Early Advanced IBD Therapy with Patient Priorities
Jessica Allegretti, MD, MPH, FACG, AGAF
Jordan E. Axelrad, MD, MPH, AGAF, FACG, FCCF
Russell D. Cohen, MD, FACG, AGAF
Jennifer Goldman, PharmD, CDCES, BC-ADM-FCCP
Francisco Javier Ampudia-Blasco, MD, PhD
Continuing the Search: New Data on Hypercortisolism Prevalence in Difficult-to-Control Metabolic Conditions
CME/CEContinuing the Search: New Data on Hypercortisolism Prevalence in Difficult-to-Control Metabolic Conditions
Christian Mende, MD, FACP, FACN, FASN, FASH, FAHA
Deepak Bhatt, MD, MPH, MBA, FACC, FAHA
DKA in the Real World: Evidence and Cases that Matter
CME/CEDKA in the Real World: Evidence and Cases that Matter
Carol Wysham, MD
Samuel Seidu, MD, FRCP(Edin), FRCGP
Leveraging CGM to Its Full Potential in People with T2D
CME/CELeveraging CGM to Its Full Potential in People with T2D
John E. Anderson, MD
Davida F. Kruger, CNP
- advertisement
DKA in Focus: What the New Consensus Means for Practice
CME/CEDKA in Focus: What the New Consensus Means for Practice
Ketan Dhatariya, MBBS, MSc, MD, MS, FRCP, PhD
Jennifer Sherr, MD, PhD
Applying Advances in Practice: Case-Based Look at Selecting Therapy for Cushing Syndrome
CME/CEApplying Advances in Practice: Case-Based Look at Selecting Therapy for Cushing Syndrome
Lewis S. Blevins, Jr, MD
James W. Suliburk, MD, FACS
Breaking Ground: 2025 Milestones in Cushing Syndrome and Looking Forward to 2026
CME/CEBreaking Ground: 2025 Milestones in Cushing Syndrome and Looking Forward to 2026
Deepak Bhatt, MD, MPH, MBA, FACC, FAHA
Amir H. Hamrahian, MD
